Condition 1: cardiac disease. Condition 2: ischemic heart disease. Angina pectoris Chronic ischemic heart disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosis of heart disease by a physician: Patients diagnosed with class I and II cardiac conditions, including coronary artery disease (CAD), congestive heart failure (CHF), cardiac arrhythmias, or angina pectoris, who do not require surgery or complex interventions. Age: Between 18 and 65 years. Hospitalization time: No more than 24 hours should have passed since admission. Willingness to participate: Patients must express their willingness to participate in the study and sign the informed consent form. Mental alertness: Patients must be fully conscious and capable of answering questions and participating in the sessions. No significant hearing or speech impairments: Patients should be able to comprehend and express concepts related to emotional intelligence and treatment adherence. No severe psychological disorders: Apart from anxiety and depression related to cardiac illness, patients with major psychiatric disorders such as severe anxiety disorders, psychotic disorders, or major depressive disorder that may prevent effective participation will be excluded.
Exclusion criteria
Exclusion criteria: Non-cooperation with the study: Patients who, for any reason (e.g., absence from educational sessions or failure to complete questionnaires), do not cooperate adequately will be excluded. Critical clinical conditions: If a patient develops a critical medical condition or requires urgent medical interventions that make participation impossible, they will be excluded. Changes in primary treatment: Patients requiring cardiac surgeries such as coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) will be excluded. Progression in disease severity: If the cardiac condition progresses to class III or IV, due to increased severity, the need for more complex treatments, or physical limitations, the patient will be withdrawn from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment adherence. Timepoint: Before the intervention, immediately after the intervention, and one month after the intervention. Method of measurement: Ziaei et al.'s Treatment Adherence questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Emotional intelligence. Timepoint: Before the intervention, immediately after the intervention, and one month after the intervention. Method of measurement: Trait Emotional Intelligence Questionnaire – Short Form (TEIQue-SF). | — |
Countries
Iran (Islamic Republic of)
Contacts
Mashhad University of Medical Sciences